Titre :
  • Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG).
Auteur : Pavlidis, N ; Aamdal, S ; Awada, Ahmad ; Calvert, H ; Fumoleau, Pierre ; Sorio, R ; Punt, Cornelis ; Verweij, Jaap ; van Oosterom, A ; Morant, Rudolf ; Wanders, Jantien ; Hanauske, Axel-R
Informations sur la publication : Cancer chemotherapy and pharmacology, 46, 2, (page 167-171)
Statut de publication : Publié, 2000
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- therapeutic use
Benzofurans -- administration & dosage
Benzofurans -- adverse effects
Benzofurans -- therapeutic use
Breast Neoplasms -- drug therapy
Colorectal Neoplasms -- drug therapy
Female
Head and Neck Neoplasms -- drug therapy
Humans
Indoles -- administration & dosage
Indoles -- adverse effects
Indoles -- therapeutic use
Infusions, Intravenous
Lymphoma, Non-Hodgkin -- drug therapy
Male
Melanoma -- drug therapy
Middle Aged
Neoplasm Staging
Neoplasms -- drug therapy
Neoplasms -- pathology
Ovarian Neoplasms -- drug therapy
Prodrugs -- adverse effects
Prodrugs -- therapeutic use
Stomach Neoplasms -- drug therapy
Note : Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Langue :
  • Anglais
Identificateurs : urn:issn:0344-5704 
info:pmid/10972487